Shares of Edgewise Therapeutics (NASDAQ:EWTX) traded flat on Wednesday after Stifel launched its coverage with a Hold recommendation, indicating a balanced risk-reward profile for the muscle drug ...
Stifel analysts maintained a Buy rating and a $42.00 price target for Halliburton (NYSE:HAL), following the company's fourth-quarter earnings report for 2024. With a current P/E ratio of 10.3x and an ...